trending Market Intelligence /marketintelligence/en/news-insights/trending/ZdSUFD_gHUlmOhBeWgMt_A2 content esgSubNav
In This List

Neovasc gets another Nasdaq noncompliance notice

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Neovasc gets another Nasdaq noncompliance notice

Neovasc Inc. fell out of compliance with a Nasdaq rule requiring listed securities to maintain a minimum bid price of $1 per share.

The Canadian medical device company's common shares had a closing bid price of below $1 for 30 consecutive business days, triggering a noncompliance notice from the Nasdaq, Neovasc said in a filing. The company has 180 calendar days, or until July 15, to comply with the rule.

Neovasc can still be eligible for additional time to comply if it does not meet the deadline, but it can also face delisting.

The noncompliance notice is the second the company has received this year, with Neovasc also falling out of compliance with the Nasdaq's minimum market value requirement Jan. 2. The company has until July 2 to comply with the rule.

Neovasc develops and sells medical devices for treating heart diseases.